Table 1.
Overall (N = 258) | Control (N = 62) | Snus trial (N = 64) | Nicorette trial (N = 67) | Ariva trial (N = 65) | Offered and tried the ST product (N = 115) | Offered but did not try the ST product (N = 81) | |
---|---|---|---|---|---|---|---|
Race–white | 65 % | 66 % | 67 % | 66 % | 60 % | 68 % | 59 % |
Race–black | 28 % | 31 % | 23 % | 27 % | 32 % | 27 % | 28 % |
Race–other | 7 % | 3 % | 9 % | 7 % | 8 % | 5 % | 12 % |
Age–under 30 yearsb | 38 % | 27 % | 36 % | 39 % | 51 % | 44 % | 38 % |
Age–30 to 50 years | 38 % | 35 % | 41 % | 36 % | 38 % | 39 % | 37 % |
Age–over 50 yearsb | 24 % | 37 % | 23 % | 25 % | 11 % | 17 % | 25 % |
Female | 44 % | 39 % | 41 % | 51 % | 45 % | 38 %c | 55 % |
Income–below 30 K | 57 % | 56 % | 63 % | 49 % | 58 % | 54 % | 60 % |
Income–between 30 and 60 K | 10 % | 19 % | 09 % | 10 % | 11 % | 14 % | 14 % |
Income–over 60 K | 15 % | 10 % | 11 % | 13 % | 17 % | 10 % | 10 % |
Income–chose not to reveal | 18 % | 15 % | 17 % | 27 % | 14 % | 22 % | 16 % |
Moderately or very worried about future quality of life | 61 % | 61 % | 59 % | 64 % | 58 % | 62 % | 59 % |
Prior smokeless tobacco use | 43 % | 39 % | 50 % | 43 % | 38 % | 55 %c | 28 % |
Observations–NY | 36 % | 39 % | 33 % | 36 % | 38 % | 38 % | 30 % |
Observations–SC | 34 % | 35 % | 36 % | 37 % | 29 % | 32 % | 37 % |
Observations–PA | 29 % | 26 % | 31 % | 27 % | 32 % | 30 % | 31 % |
aAuctions conducted from November 2010–November 2011
bThe only demographic characteristics that differed across treatment groups at a significance level of 0.05 or less was the over 50 age group (p < 0.01). No other differences in demographic characteristics were found to be significant at the 5 % level using a chi-squared test
cThe only demographic or background characteristics where there were statistically significant differences in the percentage who tried ST products was for females (p < 0.05) and for those who had used smokeless tobacco at some point in the past (p < 0.01)